$STRR
STAR EQUITY HOLDINGS, INC.

2015 Q4 Form 10-Q Financial Statement

#000070738815000054 Filed on November 02, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q4
Revenue $15.58M $15.86M $14.14M
YoY Change 10.15% 14.27% 12.9%
Cost Of Revenue $10.89M $11.06M $9.860M
YoY Change 10.45% 16.77% 11.54%
Gross Profit $4.692M $4.802M $4.284M
YoY Change 9.52% 8.91% 16.16%
Gross Profit Margin 30.12% 30.27% 30.29%
Selling, General & Admin $4.060M $3.720M $3.340M
YoY Change 21.56% 16.1% 18.44%
% of Gross Profit 86.53% 77.47% 77.96%
Research & Development $0.00 $0.00
YoY Change -100.0%
% of Gross Profit 0.0% 0.0%
Depreciation & Amortization $700.0K $665.0K $500.0K
YoY Change 40.0% 33.8% 8.7%
% of Gross Profit 14.92% 13.85% 11.67%
Operating Expenses $4.190M $3.854M $3.440M
YoY Change 21.8% 14.12% 19.86%
Operating Profit $498.0K $948.0K $816.0K
YoY Change -38.97% -8.14% 4.62%
Interest Expense -$250.0K $11.00K $0.00
YoY Change 10.0% -100.0%
% of Operating Profit -50.2% 1.16% 0.0%
Other Income/Expense, Net -$11.00K
YoY Change -375.0%
Pretax Income $250.0K $937.0K $820.0K
YoY Change -69.51% -9.56% 3.8%
Income Tax -$430.0K $18.20M $40.00K
% Of Pretax Income -172.0% 1942.37% 4.88%
Net Earnings $678.0K $19.12M $772.0K
YoY Change -12.18% 1759.92% -1.91%
Net Earnings / Revenue 4.35% 120.54% 5.46%
Basic Earnings Per Share $0.03 $0.99 $0.04
Diluted Earnings Per Share $0.03 $0.97 $0.04
COMMON SHARES
Basic Shares Outstanding 19.42M shares 19.36M shares 18.61M shares
Diluted Shares Outstanding 19.80M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.10M $19.90M $22.00M
YoY Change -13.18% -8.72% -16.67%
Cash & Equivalents $15.87M $13.90M $14.05M
Short-Term Investments $3.200M $6.000M $7.900M
Other Short-Term Assets $764.0K $1.993M $856.0K
YoY Change -10.75% 162.24% 22.81%
Inventory $4.381M $4.325M $3.644M
Prepaid Expenses
Receivables $7.274M $8.313M $5.989M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.75M $34.75M $32.95M
YoY Change -3.66% 4.69% -10.14%
LONG-TERM ASSETS
Property, Plant & Equipment $6.252M $6.614M $4.766M
YoY Change 31.18% 34.92% 14.76%
Goodwill $2.897M $2.897M $1.337M
YoY Change 116.68% 116.68% 626.63%
Intangibles $3.079M $3.213M $2.577M
YoY Change 19.48% 20.34% 630.03%
Long-Term Investments
YoY Change
Other Assets $1.560M $1.298M $269.0K
YoY Change 479.93% 1754.29% 192.39%
Total Long-Term Assets $32.37M $30.81M $8.949M
YoY Change 261.67% 243.17% 87.14%
TOTAL ASSETS
Total Short-Term Assets $31.75M $34.75M $32.95M
Total Long-Term Assets $32.37M $30.81M $8.949M
Total Assets $64.11M $65.56M $41.90M
YoY Change 53.01% 55.47% 1.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.369M $2.797M $1.423M
YoY Change -3.79% 58.92% 132.9%
Accrued Expenses $3.500M $3.100M $3.400M
YoY Change 2.94% -8.82% -37.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $8.706M $9.904M $8.293M
YoY Change 4.98% 15.0% 8.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.252M $1.327M $963.0K
YoY Change 30.01% 49.27% 118.86%
Total Long-Term Liabilities $1.252M $1.327M $963.0K
YoY Change 30.01% 49.27% 118.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.706M $9.904M $8.293M
Total Long-Term Liabilities $1.252M $1.327M $963.0K
Total Liabilities $9.958M $11.23M $9.256M
YoY Change 7.58% 18.21% 14.77%
SHAREHOLDERS EQUITY
Retained Earnings -$93.74M -$94.42M -$115.4M
YoY Change -18.76% -18.71% -2.1%
Common Stock $2.000K $2.000K $2.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.728M $5.728M $5.728M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 2.588M shares 2.588M shares 2.588M shares
Shareholders Equity $54.16M $54.33M $32.65M
YoY Change
Total Liabilities & Shareholders Equity $64.11M $65.56M $41.90M
YoY Change 53.01% 55.47% 1.09%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q4
OPERATING ACTIVITIES
Net Income $678.0K $19.12M $772.0K
YoY Change -12.18% 1759.92% -1.91%
Depreciation, Depletion And Amortization $700.0K $665.0K $500.0K
YoY Change 40.0% 33.8% 8.7%
Cash From Operating Activities $750.0K $720.0K $1.300M
YoY Change -42.31% -58.86% -5.8%
INVESTING ACTIVITIES
Capital Expenditures -$240.0K -$300.0K -$110.0K
YoY Change 118.18% -21.05% 0.0%
Acquisitions
YoY Change
Other Investing Activities $2.730M -$230.0K $1.070M
YoY Change 155.14% -128.05% 72.58%
Cash From Investing Activities $2.490M -$530.0K $960.0K
YoY Change 159.38% -220.45% 84.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.270M -1.180M -990.0K
YoY Change 28.28% 20.41% 25.32%
NET CHANGE
Cash From Operating Activities 750.0K 720.0K 1.300M
Cash From Investing Activities 2.490M -530.0K 960.0K
Cash From Financing Activities -1.270M -1.180M -990.0K
Net Change In Cash 1.970M -990.0K 1.270M
YoY Change 55.12% -181.82% 14.41%
FREE CASH FLOW
Cash From Operating Activities $750.0K $720.0K $1.300M
Capital Expenditures -$240.0K -$300.0K -$110.0K
Free Cash Flow $990.0K $1.020M $1.410M
YoY Change -29.79% -52.11% -5.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000707388
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19416070 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
DIGIRAD CORP
CY2014Q3 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
CY2015Q3 digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
24000 shares
digirad Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
19000 shares
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1423000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2797000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5989000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8313000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-154000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-96000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22134000 USD
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22764000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
153769000 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154472000 USD
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
93000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
263000 USD
us-gaap Restructuring Charges
RestructuringCharges
659000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000 shares
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
134000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
372000 USD
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
82000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
85000 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000 shares
CY2014Q4 us-gaap Assets
Assets
41901000 USD
CY2015Q3 us-gaap Assets
Assets
65558000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
32952000 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
34745000 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
7935000 USD
CY2015Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
5986000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18744000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12793000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14051000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13895000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5951000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-156000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18615945 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19356070 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18615945 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19356070 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1019000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1684000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19123000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20978000 USD
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9472000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29109000 USD
CY2015Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11060000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32032000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1409000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
5308000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1859000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
5112000 USD
CY2014Q3 us-gaap Cost Of Services
CostOfServices
8063000 USD
us-gaap Cost Of Services
CostOfServices
23801000 USD
CY2015Q3 us-gaap Cost Of Services
CostOfServices
9201000 USD
us-gaap Cost Of Services
CostOfServices
26920000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
4409000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-18167000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1644000 USD
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1478000 USD
CY2015Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
35000000 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0 USD
CY2015Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
16791000 USD
CY2015Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
18100000 USD
us-gaap Depreciation
Depreciation
1178000 USD
us-gaap Depreciation
Depreciation
1379000 USD
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
497000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1441000 USD
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
665000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1751000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3261000 USD
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2872000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3084000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3455000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
800000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
500000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
100000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
400000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
400000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
500000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
500000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5661000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6668000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2577000 USD
CY2015Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3213000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
55000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2047000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6235000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2508000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6880000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
1337000 USD
CY2015Q3 us-gaap Goodwill
Goodwill
2897000 USD
CY2014Q4 us-gaap Goodwill Gross
GoodwillGross
1337000 USD
CY2015Q3 us-gaap Goodwill Gross
GoodwillGross
2897000 USD
us-gaap Gross Profit
GrossProfit
12356000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
4802000 USD
us-gaap Gross Profit
GrossProfit
13217000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1036000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1721000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
937000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2264000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18183000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18698000 USD
CY2015Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
18200000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1113000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1167000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1169000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2171000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-208000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-166000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-394000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-470000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-406000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
730000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-240000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-399000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-227000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
233000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-244000 USD
CY2014Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
294000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
295000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
418000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
444000 shares
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2577000 USD
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3213000 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
10000 USD
us-gaap Interest Expense
InterestExpense
27000 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
21000 USD
us-gaap Interest Expense
InterestExpense
44000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
558000 USD
CY2015Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1257000 USD
CY2014Q4 us-gaap Inventory Gross
InventoryGross
5557000 USD
CY2015Q3 us-gaap Inventory Gross
InventoryGross
5480000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
3644000 USD
CY2015Q3 us-gaap Inventory Net
InventoryNet
4325000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2439000 USD
CY2015Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3096000 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1913000 USD
CY2015Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1155000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2560000 USD
CY2015Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1127000 USD
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
14000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
46000 USD
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
10000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
32000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
9256000 USD
CY2015Q3 us-gaap Liabilities
Liabilities
11231000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41901000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65558000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8293000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9904000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2895000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2830000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6035000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-291000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2979000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2965000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
1028000 USD
us-gaap Net Income Loss
NetIncomeLoss
1703000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
19120000 USD
us-gaap Net Income Loss
NetIncomeLoss
20962000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
425000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
1340000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
3377000 USD
us-gaap Operating Expenses
OperatingExpenses
10654000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
3854000 USD
us-gaap Operating Expenses
OperatingExpenses
10941000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1032000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1702000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
948000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2276000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1789000 USD
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2543000 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
856000 USD
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1993000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
269000 USD
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1298000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-9000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-19000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
16000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
16000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
963000 USD
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1327000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
2783000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
2862000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
2617000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3447000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-3000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1147000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1181000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
173000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
432000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1095000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1869000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
81000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000 USD
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
176000 USD
CY2015Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
214000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26900000 USD
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29378000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4766000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6614000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
261000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
162000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
154000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
400000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
131000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
477000 USD
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
233000 USD
CY2015Q3 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2014Q3 us-gaap Restructuring Charges
RestructuringCharges
80000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115379000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94416000 USD
CY2014Q3 us-gaap Revenues
Revenues
13881000 USD
us-gaap Revenues
Revenues
41465000 USD
CY2015Q3 us-gaap Revenues
Revenues
15862000 USD
us-gaap Revenues
Revenues
45249000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3060000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9749000 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3880000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10525000 USD
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
10821000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
31716000 USD
CY2015Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
11982000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
34724000 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1157000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3497000 USD
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1212000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3689000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
207000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
450000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2684000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
32645000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
54327000 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2588484 shares
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2588484 shares
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5728000 USD
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5728000 USD
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3900000 USD
CY2015Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3200000 USD
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18895000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18853000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19798000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19608000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18601000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18558000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19356000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19145000 shares
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The Company</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Digirad Corporation (Digirad), a Delaware corporation, is one of the largest national providers of in-office nuclear cardiology imaging and ultrasound services, and also provides cardiac event monitoring services. These services are provided to physician practices, hospitals, and imaging centers through our Diagnostic Services reportable segment. Digirad also sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products sold, through our Diagnostic Imaging reportable segment. These </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments, Diagnostic Services and Diagnostic Imaging, are collectively referred to herein as the &#8220;Company.&#8221; </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements include the operations of both segments. Intercompany accounts and transactions are accounted for at cost and have been eliminated in consolidation. All our long-lived assets are located in the United States and substantially all of our revenues arise from sales activity in the United States. </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements included in this Form 10-Q have been prepared in accordance with the U.S. Securities and Exchange Commission (SEC) instructions for Quarterly Reports on Form 10-Q. Accordingly, the condensed consolidated financial statements are unaudited and do not contain all the information required by U.S. generally accepted accounting principles (GAAP) to be included in a full set of financial statements. The unaudited condensed consolidated balance sheet at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;"> has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by GAAP for a complete set of financial statements. The audited consolidated financial statements for our fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC on Form 10-K on March 6, 2015, include a summary of our significant accounting policies and should be read in conjunction with this Form 10-Q. In the opinion of management, all material adjustments necessary to present fairly the results of operations, cash flows, and balance sheets for such periods have been included in this Form 10-Q. All such adjustments are of a normal recurring nature. In addition, certain reclassifications have been made to the prior period financial statements to conform to the current period presentation.&#160;The results of operations for interim periods are not necessarily indicative of the results of operations for the entire year. </font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results could differ from management&#8217;s estimates.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The financial results for the three and nine months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;"> include the financial results of MD Office Solutions and Telerhythmics, LLC. See Note 3 to the unaudited condensed consolidated financial statements for more information related to the acquisition of MD Office Solutions and Telerhythmics, LLC.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncement</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued guidance that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers which supersedes most current revenue recognition guidance, including industry-specific guidance. The guidance provides that an entity recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The guidance allows for either full retrospective or modified retrospective adoption and is currently scheduled to become effective for us in the first quarter of 2018. We are currently evaluating the alternative transition methods and the potential effects of the adoption of this guidance on our financial statements.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued guidance that amends the guidelines for the measurement of inventory from lower of cost or market to the lower of cost and net realizable value (NRV). NRV is defined as the estimated selling prices in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. Under existing standards, inventory is measured at lower of cost or market, which requires the consideration of replacement cost, NRV and NRV less an amount that approximates a normal profit margin. This ASU eliminates the requirement to determine and consider replacement cost or NRV less an approximately normal profit margin for inventory measurement. The new standard is effective prospectively for fiscal years beginning after December 15, 2016. We are currently evaluating the impact, if any, of adopting this guidance on our financial statements.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2015, the FASB issued guidance which eliminates the requirement for an acquirer to retrospectively adjust provisional amounts recorded in a business combination to reflect new information about the facts and circumstances that existed as of the acquisition date and that, if known, would have affected measurement or recognition of amounts initially recognized. As an alternative, the amendment requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The amendments require that the acquirer record, in the financial statements of the period in which adjustments to provisional amounts are determined, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. The new standard is effective prospectively for fiscal years beginning after December 15, 2015, including interim periods within those fiscal years. We are currently evaluating the impact, if any, of adopting this guidance on our financial statements.</font></div><div style="line-height:120%;padding-top:6px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that no other new accounting guidance was adopted or issued during 2015 that is relevant to the readers of our financial statements. However, there are numerous new proposals under development which, if and when enacted, may have a significant impact on our financial reporting.</font></div></div>

Files In Submission

Name View Source Status
0000707388-15-000054-index-headers.html Edgar Link pending
0000707388-15-000054-index.html Edgar Link pending
0000707388-15-000054.txt Edgar Link pending
0000707388-15-000054-xbrl.zip Edgar Link pending
a1a05.jpg Edgar Link pending
digirad-20150930.xml Edgar Link completed
digirad-20150930.xsd Edgar Link pending
digirad-20150930_cal.xml Edgar Link unprocessable
digirad-20150930_def.xml Edgar Link unprocessable
digirad-20150930_lab.xml Edgar Link unprocessable
digirad-20150930_pre.xml Edgar Link unprocessable
drad-9302015x10q.htm Edgar Link pending
drad-9302015xex311.htm Edgar Link pending
drad-9302015xex312.htm Edgar Link pending
drad-9302015xex321.htm Edgar Link pending
drad-9302015xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending